Technical Standard 126 views
Finerenone in the management of diabetes kidney disease: Association of British Clinical Diabetologists (ABCD) and the UK Kidney Association (UKKA) consensus statement
M T Khine,
Steve Bain 
,
S Bellary,
T. A. Chowdhury,
D. Fogarty,
J Karalliedde,
G Goldet,
R Mallik,
R. Montero,
D Patel,
A. Sharif,
M. Wahba,
P. Winocour,
S. Zac Varghese,
I. Dasgupta,
D Banerjee,
P De,
A. H. Frankel
,
S Bellary,
T. A. Chowdhury,
D. Fogarty,
J Karalliedde,
G Goldet,
R Mallik,
R. Montero,
D Patel,
A. Sharif,
M. Wahba,
P. Winocour,
S. Zac Varghese,
I. Dasgupta,
D Banerjee,
P De,
A. H. Frankel
Swansea University Author:
Steve Bain
Abstract
Finerenone in the management of diabetes kidney disease: Association of British Clinical Diabetologists (ABCD) and the UK Kidney Association (UKKA) consensus statement
| Published: |
ABCD-UKKA joint finerenone consensus statement
The Association of British Clinical Diabetologists (ABCD) and the UKKA have jointly issued a consensus statement on finerenone in the management of diabetic kidney disease. The statement can be accessed here: https://ukkidney.org/renal-association/news/abcd-ukka-joint-finerenone-consensus-statement
2024
|
|---|---|
| Online Access: |
https://abcd.care/sites/default/files/resources/ABCD%20UKKA%20-%20Finerenone%20Consensus%20Statement.pdf |
| URI: | https://cronfa.swan.ac.uk/Record/cronfa67148 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|